Uterine fibroids are common, non-cancerous tumors of the uterus. Uterine fibroids may cause problems such as heavy menstrual periods, pain or pressure in the pelvic area or frequent urination. UVa Health System, Department of Radiology seeks adult women with uterine fibroids who are seeking treatment with MR-Guided Focused Ultrasound (The ExAblate device) for participation in a clinical trial. The purpose of this study is to collect additional data to further evaluate the safe use of the MR-Guided Focused Ultrasound with the ExAblate device using enhanced sonications for the treatment of uterine fibroids. The study would involve at least 4 visits to UVA: A screening/consultation visit, up to 2 treatment visits with the ExAblate device, and follow up clinic visits at 1 week and 1 month after the last treatment.

Financial Information

If you participate in this study, and meet eligibility requirements, the following tests and procedures will be provided at no cost to you:

• ExAblate treatment procedure(s)
  
• Urine pregnancy tests and kidney blood test required by the study
  
• MRI at baseline (if you have not already had one prior to enrolling in this study)
  
• Follow up clinic visit at 1 week after your last ExAblate treatment
  
• Quality of life questionnaires You will be responsible for travel costs associated with your visits to UVA as well as any additional charges associated with treatment for your condition that are not associated with your participation in this study.